AV研究所

If you are a Healthfirst member and received a letter regarding negotiations with NewYork-Presbyterian,
read to find the latest information.

Our team is actively involved in clinical research designed to bring the latest novel interventions to our patients, while promoting scientific advancement of the head and neck cancer field.

Eligible patients within the Head and Neck Cancer Program have access to clinical trials. .